Article info

Download PDFPDF

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Authors

  • Kelvin Chan Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada Department of Oncology, Provincial Drug Reimbursement Programs, Cancer Care Ontario, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Seungree Nam Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Bill Evans Department of Oncology, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Claire de Oliveira Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Alexandra Chambers Provincial Drug Reimbursement Programs, pCODR/CADTH, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Scott Gavura Department of Oncology, Provincial Drug Reimbursement Programs, Cancer Care Ontario, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jeffrey Hoch Department of Public Health Sciences, University of California Davis, Davis, California, USA PubMed articlesGoogle scholar articles
  • Rebecca E Mercer Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada Department of Oncology, Provincial Drug Reimbursement Programs, Cancer Care Ontario, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Wei Fang Dai Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada Department of Oncology, Provincial Drug Reimbursement Programs, Cancer Care Ontario, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jaclyn Beca Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada Department of Oncology, Provincial Drug Reimbursement Programs, Cancer Care Ontario, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Mina Tadrous Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Wanrudee Isaranuwatchai Centre for exceLlence in Economic Analysis Research (CLEAR), St. Michael's Hospital, Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada Health Intervention and Technology Assessment Program, Royal Thai Government Ministry of Public Health, Nontaburi, Thailand PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kelvin Chan; kelvin.chan{at}sunnybrook.ca
View Full Text

Citation

Chan K, Nam S, Evans B, et al
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Publication history

  • Received July 10, 2019
  • Revised November 14, 2019
  • Accepted December 5, 2019
  • First published January 7, 2020.
Online issue publication 
January 07, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.